Book in the news: how the US got hooked on prescription drugs
Book review: American Overdose Chris McGreal's meticulously researched book looks at what's behind America's deadly opioid addiction epidemic.
In the US, prescription painkillers accounted for 17,000 deaths in 2016. The wider opioid crisis has killed 350,000 people over 20 years. Chris McGreal provides "a detailed and compelling account of the spread of opioid addiction across the so-called rust belt, said to be the deadliest drug epidemic in American history", says Andrew Anthony in the Guardian.
McGreal provides "meticulous research" on the causes of the problem, says David Cohen in the Evening Standard. The resulting book will "make uncomfortable reading for the Sackler family, as it accuses their company Purdue Pharma "of setting off the deadliest drug crisis in history".
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Purdue's prescription opioid OxyContin had "unprecedented strength", but Purdue "realised that chronic pain sufferers were where the real money was to be made", so successfully pushed the US regulator to widen its use.
Despite making a strong case against Purdue, the author "does not find the smoking gun proof that Purdue knew OxyContin was more, not less addictive than the alternatives, says James McConnachie in the Sunday Times. And the Sacklers are far from the only villains of the piece "blinkered and compliant regulators", corrupt medical clinics and a system that allows billions of dollars to be spent on direct marketing to doctors and lobbying politicians and regulators must all share the blame.
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
Matthew graduated from the University of Durham in 2004; he then gained an MSc, followed by a PhD at the London School of Economics.
He has previously written for a wide range of publications, including the Guardian and the Economist, and also helped to run a newsletter on terrorism. He has spent time at Lehman Brothers, Citigroup and the consultancy Lombard Street Research.
Matthew is the author of Superinvestors: Lessons from the greatest investors in history, published by Harriman House, which has been translated into several languages. His second book, Investing Explained: The Accessible Guide to Building an Investment Portfolio, is published by Kogan Page.
As senior writer, he writes the shares and politics & economics pages, as well as weekly Blowing It and Great Frauds in History columns He also writes a fortnightly reviews page and trading tips, as well as regular cover stories and multi-page investment focus features.
Follow Matthew on Twitter: @DrMatthewPartri
-
Four AI ETFs to buy
Is now a good time to buy AI ETFs? We examine four AI ETFs that investors might want to add to their portfolio
By Dan McEvoy Published
-
Chase boosts easy-access interest rate - savers could earn 4.75%
Chase is offering a boosted interest rate which is fixed for six months, on top of the standard variable rate
By Jessica Sheldon Published